Dr. May on Olaratumab Activity in Pediatric Bone and Soft Tissue Sarcoma

3 意见
administrator
administrator
07/18/23

Caitlin May, PhD, postdoctoral research fellowship at Eli Lilly and Company, discusses olaratumab's (Lartruvo) demonstrating anti-tumor activity in models of pediatric bone and soft-tissue sarcoma.

  • 类别

显示更多

0 注释 排序方式

没有找到评论

脸书评论

下一个